Home/Filings/4/0001724521-23-000008
4//SEC Filing

Nuyten Dimitry SA 4

Accession 0001724521-23-000008

CIK 0001724521other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:47 PM ET

Size

5.1 KB

Accession

0001724521-23-000008

Insider Transaction Report

Form 4
Period: 2023-09-18
Nuyten Dimitry SA
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2023-09-18$20.40/sh3,708$75,64373,591 total
Footnotes (2)
  • [F1]Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person.
  • [F2]Includes 799 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001776564

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:47 PM ET
Size
5.1 KB